H2A.Z association with specific genomic loci is thought to contribute to a chromatin structure that promotes transcription activation. Acetylation of H2A.Z at promoters of oncogenes has been linked to tumorigenesis. The mechanism is unknown. Here, we show that in triple negative breast cancer cells, H2A.Z bound to the promoter of the constitutively, weakly expressed cyclin D1 oncogene (CCND1), a key regulator of cellular proliferation. Depleting the pool of H2A.Z stimulated transcription of CCND1 in the absence of its cognate transcription factor, the estrogen receptor (ER). During activation of CCND1, H2A.Z was released from the transcription start site (TSS) and downstream enhancer (enh2) sequences. Concurrently, acetylation of H2A.Z, H3 and H4 at the TSS was increased but only H2A.Z was acetylated at enh2. Acetylation of H2A.Z required the Tip60 acetyltransferase to be associated with the activated CCND1 on both TSS and enh2 sites. Depletion of Tip60 prevented CCND1 activation. Chromosome conformation capture experiments (3C) revealed specific contacts between the TSS and enh2 chromatin regions. These results suggest that release of a histone H2A.Z-mediated repression loop activates CCND1 for transcription. Our findings open new avenues for controlling and understanding aberrant gene expression associated with tumorigenesis.
INTRODUCTION
Estrogens are intimately linked to hormone-dependent breast cancer progression by promoting G1-S transition through regulation of key cell cycle regulatory factors including induction of cyclin D1, MYC, HER2 and c-SRC and repression of cyclin G2, caspase 9 and p21.
1,2 17b-estradiol (E2) functions are mediated by specific estrogen receptors (ERs), which are transcription factors belonging to the nuclear receptor family. 3 Two ERs, ERa and ERb, each expressed as several isoforms, have been characterized. [4] [5] [6] A majority of breast tumors (about 80%) express both receptors and are hormone-dependent for growth. These tumors are less invasive and generally not metastatic. 7 In contrast, ERa-negative breast tumors (ERa À ) are hormone-independent for proliferation, more invasive and prone to metastasize. 8 In ERa À cell lines, both ESR1 and ESR2 encoding ERa and ERb respectively, are silenced together with many ER-target genes including pS2/TFF1 and the progesterone receptor gene (PGR). On the other hand, another group of ER target genes including cathepsin D (CTSD), VEGF or cyclin D1 (CCND1) escape transcriptional regulation. 9, 10 Cyclin D1, encoded by the CCND1 gene, is a D-type cyclin whose growth factor-induced expression and accumulation are tightly controlled. [11] [12] [13] Cyclin D1 regulates G1-S progression and gene expression via chromatin modifications and a plethora of cellular functions (for a review see 14 ) . Its relative abundance has major effects on cell growth and metabolism via cell cycle regulated dosage of its expression.
15 CCND1 transcription is regulated by an estrogen-regulated cell-type-specific enhancer and is cell cycle regulated in ER-positive breast cancer cells (ERa þ , MCF-7 cells). 15, 16 Downregulation of Cyclin D1 has nevertheless been shown to increase migratory capacity and is associated with poor prognosis. 17, 18 CCND1 expression is low, and hormone-and cell cycle-independent in ERa À MDA-MB231 cells 9, 19 (unpublished observations). The CCND1 ORF spans 14 kb and is flanked by 5 0 and 3 0 enhancers identified by Eeckhoute et al. 16 as DNAse I hypersensitive site, to which transcription factors are recruited in estrogen responsive ERa þ cells. 16, [19] [20] [21] The 3 0 enhancer (enh2) defined as a major site of CCND1 regulation in these cells, was thought to be dysfunctional in ERa À MDA-MB231 cells. It is plausible that the lack of enh2 function relates to poor CCND1 transcription. To date the mechanisms responsible for the loss of hormonal regulation of gene expression, and subsequently of proliferation and differentiation processes, are not fully understood. In addition to aberrant DNA methylation, an unidentified epigenetic mark imposes formation of a chromatin state that forms a barrier to ERa binding in hormone-independent cell lines. 22 Epigenetic or chromatin marks are thought to mediate a functional dialog with DNA-binding factors to coordinate the activity of cis-regulatory elements in space and time. Chromatin properties can be regulated by DNA methylation and histone post-translational modifications, but also by replacement of histones with variants. [23] [24] [25] [26] [27] [28] [29] Incorporation of histone H2A.Z into the chromatin of inactive gene promoters and its removal according to physiological signals participates in regulating gene expression. [30] [31] [32] [33] H2A.Z is principally found at the promoters of poised genes and released during gene activation in both yeast and human cells. 31, [34] [35] [36] In euchromatin, a sharp peak of H2A.Z is seen at the 5 0 end of numerous genes and at enhancers. 37 A recent genome-wide analysis 38 showed that acetylated H2A.Z is generally found near the transcription start site (TSS) of active genes in prostate cancer cells.
Here 16 but not to distant upstream sites in two distinct cell lines, MDA-MB231 ( Figure 1a ) and MDA-MB436 (Supplementary Figure S1A ). H2A.Z was also present at the promoters of the silent ER-target genes, PGR, TFF1 or ESR1 (Supplementary Figure  S1B) . ChIP-on-chip experiments confirmed that H2A.Z associated exclusively with flanking regions of all tested genes and, in particular, the enh2 sites of CCND1 (J Eeckhoute, data not shown). The presence of H2A.Z at these regulatory elements in ERa À MDA-MB231 cells, prompted us to assess its potential role in transcriptional repression of these genes. To this end, we selectively depleted H2A.Z by small interference RNA (siRNA) (Figure 1b, Supplementary Figures S1C, D) . Seventy-two hours following siRNA transfection, CCND1 mRNA levels increased fourfold compared with mock-transfected cells (Figure 1b) , whereas PGR, TFF1 and ESR1 remained silent (Figure 1b ). Under these conditions, a potential role of the ER in stimulating CCND1 expression could thus be excluded (Figure 1b) . ChIP confirmed that H2A.Z siRNA treatment lead to markedly reduced binding of H2A.Z to the CCND1 TSS (Figure 1c left panel) . Concomitant to increased mRNA levels, polymerase II (pol II) recruitment to the CCND1 TSS slightly increased. In contrast, decreased H2A.Z binding to the PGR promoter did not allow polymerase II recruitment to this silent gene (Supplementary Figure S1E) . Thus, H2A.Z eviction is sufficient to stimulate CCND1 transcription in ERa À breast cancer cells. Yet, its depletion alone cannot restore the expression of silenced genes as PGR, TFF1 or ESR1.
We next asked whether activation of CCND1 following release of H2A.Z from the TSS also altered the chromatin structure of the downstream enhancer enh2, previously shown to be inactive in these cells. 16 In H2A.Z siRNA transfected cells, H2A.Z binding to enh2 was significantly diminished (Figure 1c, right panel) . In addition, CCND1 activation in siH2A.Z-transfected MDA-MB231 cells was accompanied by a strong recruitment of pol II to enh2 (Figure 1c , right panel), as described previously for E2 stimulated MCF-7 cells. 16 We conclude that enh2 has an active role in ER-independent CCND1 activation. H2A.Z seemed to interfere with stimulation of transcription when bound to TSS and enhancer sequences of CCND1. We investigates how modulating incorporation of this histone variant regulates gene activity.
H2A.Z acetylation correlates with activation of CCND1 transcription Recently, Valdes-Mora et al. 38 demonstrated in a genome-wide study that H2A.Z acetylation marks chromatin at the TSS of active genes, which are frequently deregulated in prostate cancer cells. Thus, we examined whether acetylation of H2A.Z was involved in CCND1 function in breast cancer cells. A variety of inhibitors allow modulation of histone post-translational modifications with the aim to alter gene expression patterns. Exposure of mammary tumor cell lines to trichostatin A (TSA), a pan HDACi of class 2 HDACs, reduces their growth rate 39 and induces changes in gene expression patterns. [40] [41] [42] [43] [44] We tested whether TSA would stimulate CCND1 expression. MDA-MB231 cells were cultivated in normal media and exposed to 50 ng/ml TSA for 24 h before mRNA quantification. CCND1 mRNA increased four-fold in treated compared with untreated cells (Figure 2a ). We also noticed that TSA treatment negatively affected H2AFZ mRNA levels, which were reduced B2-fold (Figure 2a) . The ESR1 gene remained silent as previously shown 22 excluding the possibility that stimulation of CCND1 was due to binding of ERa in these TSA treated ERa À cells. These results prompted us to further investigate the mechanism by which transcription of CCND1 was stimulated.
As expected, concomitant to increased transcription in the presence of TSA, acetylation of histone H3 at the CCND1 TSS increased (Figure 2b ). In these cells, H3 was also acetylated at enh2 suggesting that this enhancer participates in CCND1 activation (Figure 2b ). We show that H2A.Z was associated with the CCND1 TSS and that a fraction of this histone variant was evicted from the TSS in response to TSA treatment of MDA-MB231 cells (Figure 2c ). Interestingly, upon eviction from the TSS, H2A.Z was also lost from enh2 (Figure 2d ). Under the same conditions, we monitored binding of acetylated H2A.Z (Ac-H2A.Z) to the CCND1 TSS and enh2 using an antibody that specifically recognizes H2A.Z acetylated at K4, K7 and K14 (see Materials and methods). The amount of Ac-H2A.Z present at the CCND1 TSS or enh2 did not vary following TSA treatment. However, the ratio of Ac-H2A.Z was greatly augmented relative to the total, sharply reduced amount of H2A.Z detected at these sequences (Figures 2c and d right panel).
Based on the fact that TSA negatively affected H2AFZ mRNA levels ( Figure 2a ) we wondered whether stimulation of CCND1 was the result of increased histone acetylation or of a reduction of H2A.Z abundance. We then analyzed if depletion of the cellular pool of H2A.Z also altered Ac-H2A.Z binding at the stimulated CCND1 locus. We found nearly three-fold greater amounts of acetylated H2A.Z at the TSS (Figure 3a siH2A.Z-transfected cells ( þ ) compared with scrambled siRNA ( À ) treated MDA-MB231 cells. As the total amount of H2A.Z was reduced three-fold at these sites upon H2A.Z depletion, the relative ratio of Ac-H2A.Z to total H2A.Z increased significantly (Figures 3a and b, right panels).
In conclusion, these results reveal that the presence of hypoacetylated H2A.Z at the proximal promoter around the TSS and at the 3 0 enhancer negatively controls CCND1 expression in triple negative mammary tumor cells. Reducing the pool of free H2A.Z led to an increase in the amount of Ac-H2A.Z present at both regulatory sequences at the expense of unmodified H2A.Z. We therefore attempted to identify the factors involved in acetylation of H2A.Z and chromatin modifications associated with CCND1 transcriptional activation.
Recruitment of Tip60 and H2A.Z acetylation regulates enhancer chromatin structure Histone acetylation has long been associated with active transcription 45, 46 and thus the increase in acetylation of H2A.Z bound to the CCND1 locus may be part of general acetylation of chromatin in MDA-MB231 cells. Indeed, acetylation of H3K9 and H4 increased upon depletion of H2A.Z by siRNA at the proximal promoter (Figures 4a and b, upper panel) . Global acetylation was accompanied by the recruitment of elongating pol II phosphorylated at serine 5 (P-Ser 5; Figure 4d 
Z eviction in these ERa
À cells (Figure 4c ). In contrast to previous observations in prostate cancer cells, 38 nucleosome density did not vary at the promoter of the activated CCND1 gene. However, decreased nucleosome density at enh2 points to chromatin decondensation usually associated with DNAse I hypersensitive sites, which reinforces the notion that the enh2 site is a key element for CCND1 gene activation. 16 P-ser 5 binding did not vary at the 3 0 end of the gene as expected 47 ( Figure 4d , lower panel). Hence, acetylation of chromatin is linked to transcription initiation and elongation near the 5 0 end of CCND1 while acetylation of H2A.Z characterized the active state at both the TSS and the 3 0 enh2. Several studies in yeast have shown that the NuA4 (an ortholog of the human Tip60/p400 complex) and the SAGA histone acetyltransferase complexes acetylate multiple lysine residues of H2A.Z. [48] [49] [50] Tip60 could then be one of the HATs capable of acetylating H2A.Z in mammalian cells. Indeed, we found that Tip60 was recruited to both the TSS and enh2 of the activated CCND1 gene in MDA-MB231 cells transfected with siH2A.Z (Figure 5a ). Upon overexpression of Tip60 in MDA-MB231 cells (Supplementary Figure S2A) CCND1 expression increased nearly two-fold (Figure 5b ), whereas transcription levels of ESR1 and H2AFZ remained unchanged (Supplementary Figure S2B) . The selective knockdown of Tip60 did not affect the basal, uninduced expression level of CCND1 (Figure 5c, Supplementary Figure S2C ), but prevented gene activation upon H2A.Z depletion (Figure 5c , Supplementary Figure S2D ). In the absence of Tip60, the amount of H2A.Z and pol II bound to the TSS and enh2 of CCND1 did not vary (Figure 5d ) but the presence of acetylated H2A.Z was markedly reduced. We conclude from these ChIP experiments that Tip60 has a central role in CCND1 activation independently of E2 and is the likely candidate for acetylating H2A.Z at both TSS and enh2 sites.
Acetylation of H2A.Z regulates promoter/enhancer crosstalk via loop formation To investigate whether the CCND1 TSS interacts with enh2, we used a chromatin conformation capture (3C) assay, 51, 52 which detects physical proximity between distal DNA sites by ligation of cross-linked restricted DNA fragments (Figure 6a ). Ligation products between enh2 and promoter sequences, and between 
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enh2 and a control fragment inside the CCND1 ORF were amplified and normalized to the amplified enh2 PCR product used in ChIP experiments (see Materials and methods; Figure 6b ). We measured significant interaction frequencies between enh2 and promoter sequences in MDA-MB231 transfected with scramble siRNA (control) while in cells transfected with siH2A.Z, this interaction was reduced more than five-fold (Figure 6b ). In contrast, depletion of Tip60 alone or in combination with siH2A.Z did not affect contact frequencies between these sites (Figure 6b) . No amplification was observed between enh2 and the internal control fragment. We did not detect amplification of any of these fragments in undigested samples. Hence, an intragenic loop mediated by specific promoter-enhancer interactions is present when CCND1 expression is low (Figure 5c ). Upon transcription activation, gene lopping is markedly reduced. In conclusion, we propose a model ( Figure 7 ) in which looping of the CCND1 5 0 and 3 0 ends is mediated by histone H2A.Z and exerts repressive effects. Acetylation of H2A.Z by Tip60 reduces interactions between TSS and enh2 sites, creating a chromatin environment favorable for transcriptional activation. 38 reported in a genome-wide study of normal and prostate cancer cells, that acetylation of H2AZ at the TSS correlated with activation of oncogenes and that reduced H2A.Z acetylation marked silenced tumor suppressor genes. 38 Here we extend these findings to breast cancer cells. In addition, we propose a mechanism by which H2A.Z acetylation modulates transcription associated with deregulated gene activity in cancer cells.
Reducing the pool of H2A.Z resulted in release of H2A.Z from promoter and enhancer sequences and increased CCND1 expression. This is consistent with the previously proposed model that nucleosomes containing H2A.Z are more labile. Eviction of H2A.Z thus promotes chromatin accessibility. 53 It is tempting to speculate that modulation of the 3D intragenic organization may be key for creating a window of opportunity for secondary factors to regulate transcription. Hence, not the action of specific transcription factors and downstream events resulting from their association once favorable conditions are encountered, 54 but structure would guide activity. Concomitantly to chromatin reorganization, acetylation of the remaining H2A.Z, but not of other histones, was a characteristic feature of chromatin in the 3 0 enhancer region, suggesting that this modification specifically regulates 3D organization of genetic loci.
Enhancers are thought to allow transcription activators to bind inactive genomic loci in order to facilitate the onset of transcription. This usually involves chromatin modifying complexes 55 such as CBP/p300 in mammalian cells. 56, 57 Here we show that Tip60, a histone acetyltransferase that has been shown to acetylate histones H3, H4, H2A, 58, 59 and H2AX 60 in vivo, is recruited to a 3 0 enhancer of the CCND1 gene upon activation. Tip60 is an essential cofactor for numerous transcription factors and important for cell proliferation. Binding to promoter and enhancer sequences of the stimulated CCND1 gene coincided with an increased ratio of acetylated H2A.Z. Thus, for the first time, we provide evidence for a role of Tip60 in transcriptional activation of the CCND1 oncogene in ERa À breast cancer cells potentially by acetylation of the histone variant H2A.Z. Replacement of H2A by H2A.Z alters nucleosome conformation creating docking sites for distinct cofactors and chromatin remodelers. 61, 62 Tip60 could therefore be recruited to H2A.Z containing loci as has been demonstrated for the NuA4 complex in yeast. 48 We hypothesize that Tip60 is capable of regulating CCND1 gene expression by acetylating H2A.Z at the downstream enh2, which then disturbs repressive promoter enh2 crosstalk. Here, ERa was not required for Tip60 recruitment to these CCND1 regulatory elements unlike the mechanism recently described in ER þ cells. 62 Our data thus illustrate that the expression levels of tissue or cell-specific genes are largely modulated by the ability of transacting factors to associate with regulatory elements.
Long-range interactions between distant enhancers and promoter regions via chromatin looping has been shown to allow activation of single genes or gene clusters. [63] [64] [65] [66] This looping generally occurs in the 5 0 part of genes and over tens or hundreds of kb. The role of such loops is thought to isolate chromatin from surrounding repressive environment via insulator elements. 67 Long-range intragenic interactions implicate transcription activators, histone variants, including H2A.Z and macro H2A.1, and chromatin remodelers bound to promoter and enhancer regions, but direct experimental evidence for intragenic looping is still lacking. 19, 30, 68, 69 As shown by results of large-scale chromosome conformation (4C) and ChiA-PET experiments, such interactions are well correlated with the existence of chromatin domains of distinct properties around highly regulated genes, [70] [71] [72] via interchromosomal but also intrachromosomal loops, but their functional significance remains to be established. However, dynamic chromosome folding within distinct domains accompanies transcription activation 73, 74 (Kocanova et al., unpublished data) . It is thus plausible that local decondensation of chromatin is, at least in part, the result of releasing looping.
Finally, H2A.Z associates with a subset of ER-target genes that are differentially regulated in different breast cancer cell lines. Hormone treatment can lead to recruitment of H2A.Z to the TSS of the TFF1 gene 30 or its eviction at the PGR or CCND1 promoters (unpublished observations) in MCF-7 cells. These data suggest that there is no general mechanism linking H2A.Z binding to transcription regulation. Indeed, H2A.Z was also associated with silenced or repressed genes in ER À breast cancer cells. Similarly to prostate cancer cells, it is the acetylation of H2A.Z that has a key role in transcription regulation of genes in breast cancer cells. The ratio of acetylated relative to bulk H2A.Z bound to TSS and 3 0 enhancer sequences controls gene function. Modification of this ratio allowed reversing uncontrolled gene expression in the more aggressive ER À breast cancer cells for which targeted treatments are critically lacking. Interfering with the ratio of bound acetylated H2A.Z to promoter and enhancer sequences in ER À cells mimics the effect of the estradiol bound ER. This mechanism may increase our understanding of tumorigenesis and offer new perspectives for re-activating control gene pathways.
MATERIALS AND METHODS
Cell lines, transfection and western blotting. Figure  S1D) . 75 Tip60 siRNA 76 was purchased from Eurogentec, and transfected with Interferine (Ozyme) according to the manufacturer's protocol. A total of 3 Â 10 5 MDA-MB231 cells were seeded in six-well plates. Seventy-two hours following siRNA transfection, total cell extracts were isolated and protein level of H2A.Z and Tip60 was analyzed by immunoblotting on gel SDS-PAGE 15% with anti-H2A.Z (Abcam, Cambridge, UK, ab4174), antiTip60 76 and with anti-GAPDH (Millipore, Bedford, MA, USA, mab374) or anti-Tubulin (Sigma, DM1A) antibodies as loading control.
RNA analysis.
Total RNA was extracted using an RNeasy mini-kit (Qiagen, Valencia, CA, USA) and eluted with 35 ml of RNAase-free water. First strand cDNA was generated using 2 mg of total RNA in a reaction containing random oligonucleotides as primers with the ThermoScript RT-PCR system (Invitrogen). Real-time PCR was performed on a Mastercycler ep realplex 
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ChIP assays
ChIP analyses were performed as described previously 77 from MDA-MB231 cells. Samples were sonicated to generate DNA fragments o500 bp. Chromatin fragments were immunoprecipitated using antibodies against H2A.Z (ab4174, Abcam), Acetyl H2A.Z (ab18262, Abcam), RNA pol II (N20X, Santa Cruz biotechnology, Santa Cruz, CA, USA), Acetyl H3K9 (06-942 
3C assays
Chromatin conformation capture assays were performed essentially as described, 52 with only minor modifications. MDA-MB231 cells were transfected with a scrambled control siRNA ( À ), with H2A.Z SMARTpool siRNA ( þ ) (Dharmacon Thermo Scientific), Tip60 siRNA ( þ ) or both siRNAs and cultured in phenol red-free DMEM containing 10% FBS-T for 72 h before cross-linking. The culture medium was removed, and cells were fixed with 1.5% formaldehyde for 10 min at room temperature. Cells were then washed twice with cold phosphate-buffered saline solution, and resuspended in icecold lysis buffer (10 mm Tris-HCl, pH 8.0, 10 mm NaCl, 0.2% nonidet P-40, and protease inhibitor mixture). Nuclei were resuspended in 1 ml of buffer B 1.2X buffer (MBI Fermentas, Thermo Fisher Scientific, Rockford, IL, USA) supplemented with SDS 0.3%. Triton X-100 1.8% was added to sequester the SDS and incubated for 1 h at 37 1C. The cross-linked DNA was digested overnight with 400 units of restriction enzyme Csp6I (MBI Fermentas). The restriction enzyme was inactivated by incubation at 65 1C for 20min The reactions were diluted with ligase buffer (50 mm Tris-HCl, pH 7.5, 10 mm MgCl 2 , 10 mm dithiothreitol, 1 mm ATP and 25 mg/ml bovine serum albumin), supplemented with Triton X-100 (1% final concentration). The DNA was ligated using T4 DNA ligase (New England Biolabs, Ipswich, MA, USA) overnight at 16 1C and an additional 100 units for 2 h at 37 1C. RNase was added for 30 min at 37 1C, and samples were incubated with SDS overnight at 70 1C to reverse the crosslink. The following day, samples were incubated for 2 h at 45 1C with proteinase K, and the DNA was purified by phenol-chloroform extractions and ethanol precipitation. Interaction between chromatin domains was assessed by PCR amplification carried out using similar conditions as for real-time PCR amplification but with four nested primer pairs for each predicted ligation event (four possibilities) as performed by Deschenes et al. 79 with minor modifications. The second PCR reaction was performed and analyzed by q-PCR. Primers were designed on the digested BAC fragments, directly around the putative site of ligation for the four possibilities. BAC clones RP11-300ID (BACPAC Resources Center at Childrens Hospital Oakland Research Institute, Oakland, CA, USA) containing the CCND1 gene and downstream 160-kb region were used. Forty microgram of BAC was digested by Csp6I overnight and ligated. This product was purified by phenol-chloroform and precipited in order to generate 3C control templates. PCR primer efficiency was measured by amplifying 0.01-50 ng of digested BAC product and also tested on a fixed amount (50 ng) of digested genomic DNA. All primers have an annealing temperature between 65 to 70 1C and a product size around 150-300 bp. All primer combinations showed PCR efficiency between 90 and 100%. chromatin conformation capture assay results are presented as the average from three independent preparations of 3C DNA, followed by q-PCR analysis in triplicate. q-PCR for enh2 (PCR primers designed inside the Csp6I restriction fragment including enh2) was used as an internal control to verify ligation events. Nondigested samples and ligation between a control fragment with enh2 are represented. List of primer sequences see Supplementary Figure S3 .
